NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) announced that it will host a virtual investor event on June 23, 2025, at 8:00 am ET. The event will focus on the firmonertinib clinical program for the treatment of EGFR PACC mutant non-small cell lung cancer (NSCLC).
Register for the event now by clicking here and secure your spot today!
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.